Interactive Breakout Discussions

Interactive Breakout Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by facilitators who keep the discussion on track and the group engaged. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing. Interactive breakout discussions are in-person only.

AFTERNOON SESSION ON DAY 1 | MONDAY 3 OCTOBER AT 15:50 CEST

TABLE 1: Strategies for Patient-Centric Trial Design and Digital Patient Engagement to Improve Outcomes and Diversity
Moderators:
Howard Turner, Senior Clinical Operations Lead, Roche
Nadia Khaled, Clinical Digital Transformation Lead, Nestle Research Ctr
Rosanne Janssens, PhD, Postdoctoral Researcher, Pharmaceutical Sciences, KU Leuven
Paul Duffy, Head, Global Clinical Site Partnerships, MSD
Angela Bilkhu, Global Patient Partnership Director, R&D, Solid Tumor, Roche

  • How can industry learn from patients, caregivers, HCPs, sites and each other to better design less burdensome and more efficient trials?
  • How can we rethink the use of data, technology, social science, and novel approaches to design truly patient-centered trials and ensure greater trial diversity?
  • What are current digital patient projects gaining traction, engagement pilots, new technologies, the role of patient communities?
  • What is a complete digital patient experience? What is required to make this a reality for all trials? Where and why do solutions and technologies still fall short in making an impact for patients?

TABLE 2: Data Management Strategies to Ensure Quality and Improve Analytics
Moderators:
Marcin Makowski, PhD, Head, Centralized Monitoring & Data Analytics, GlaxoSmithKline
Marion Wolfs, Head, Senior Director, Risk Management & Central Monitoring, Janssen Pharmaceutical Companies of Johnson & Johnson

  • Risk Based Clinical Data Management approaches
  • RWD to accelerate design and execution of clinical trials
  • Innovative technologies and processes to ensure quality data
  • Elevating data insights to action